Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Dec;81(7):1234-7.
doi: 10.1038/sj.bjc.6690834.

Serum carotenoids and vitamins and risk of cervical dysplasia from a case-control study in Japan

Affiliations
Free PMC article

Serum carotenoids and vitamins and risk of cervical dysplasia from a case-control study in Japan

C Nagata et al. Br J Cancer. 1999 Dec.
Free PMC article

Abstract

The relationships between risk of cervical dysplasia and dietary and serum carotenoids and vitamins were investigated in a case-control study. Cases were 156 women who attended Papanicolaou test screening in nine institutes affiliated with Japan Study Group of Human Papillomavirus (HPV) and Cervical Cancer and had cervical dysplasia newly histologically confirmed. Age-matched controls were selected from women with normal cervical cytology attending the same clinic. Blood sample and cervical exfoliated cells were obtained for measuring serum retinol, alpha-carotene, beta-carotene, zeaxanthin/lutein, cryptoxanthin, lycopene and alpha-tocopherol and for HPV detection. Higher serum level of alpha-carotene was significantly associated with decreased risk of cervical dysplasia after controlling for HPV infection and smoking status (odds ratio (OR) = 0.16, 95% confidence interval (CI) 0.04-0.62 for the highest as compared with the lowest tertile). Decreased risk for the highest tertile of serum lycopene (OR = 0.28) was marginally significant. Decreased risks observed for the highest tertiles of beta-carotene (OR = 0.65) and zeaxanthin/lutein (OR = 0.53), were not statistically significant.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Science. 1984 May 11;224(4649):569-73 - PubMed
    1. Gynecol Oncol. 1997 Jun;65(3):483-92 - PubMed
    1. Gynecol Oncol. 1988 Jun;30(2):187-95 - PubMed
    1. J Natl Cancer Inst. 1988 Jun 15;80(8):580-5 - PubMed
    1. Int J Cancer. 1989 Jun 15;43(6):1050-4 - PubMed

Publication types